Komori
Other Disclosures4591RIBOMIC Inc.Pharmaceuticals

Notice of Participation in the "Bio IR Day" Company Briefing for Individual Investors

The Company disclosed that its president is scheduled to speak at the “Bio IR Day” company briefing for individual investors on 7 July 2026, where he will explain the Company’s business activities and growth strategy.

Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

“Bio IR Day” company briefing for individual investors
Applicable field (uses covered by this announcement)

IR for individual investors; company briefing for a biotech venture

Launch date7 July 2026 (scheduled; briefing date)
Relationship between the counterparty and the company
RIBOMIC Inc.4591
Relationship with the Company

The Company will participate in and speak at the briefing organized by 日本証券新聞社 and co-organized by グロースキャピタル株式会社. Capital and personnel relationships are not disclosed.

Counterparty日本証券新聞社, グロースキャピタル株式会社

日本証券新聞社 is the organizer of the briefing, and グロースキャピタル株式会社 is the co-organizer. Other details are not disclosed.

Location (as indicated in this announcement)

Tokyo Securities Kaikan 8th-floor hall (1-5-8 Nihonbashi-Kayabacho, Chuo-ku, Tokyo)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services Covered“Bio IR Day” company briefing for individual investors
Counterparty日本証券新聞社, グロースキャピタル株式会社
Counterparty overview日本証券新聞社 is the organizer of the briefing, and グロースキャピタル株式会社 is the co-organizer. Other details are not disclosed.
Relationship with the CompanyThe Company will participate in and speak at the briefing organized by 日本証券新聞社 and co-organized by グロースキャピタル株式会社. Capital and personnel relationships are not disclosed.
Launch date7 July 2026 (scheduled; briefing date)
Applicable areaIR for individual investors; company briefing for a biotech venture
LocationTokyo Securities Kaikan 8th-floor hall (1-5-8 Nihonbashi-Kayabacho, Chuo-ku, Tokyo)
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To explain the Company's business activities and growth strategy to individual investors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Participation in the "Bio IR Day" Company Briefing for Individual Investors | RIBOMIC Inc. (4591) timely disclosure | Komori